Isoflavone metabolites

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 311/38 (2006.01) A23L 1/30 (2006.01) A61K 31/12 (2006.01) A61K 31/352 (2006.01) C07C 49/245 (2006.01) C07C 49/248 (2006.01) C07C 49/255 (2006.01) C12N 1/00 (2006.01) C12P 7/26 (2006.01) C12P 17/06 (2006.01)

Patent

CA 2371765

There are disclosed compounds of formulae (I) or (II) in which A is selected from the group consisting of (1), (2), (3) and (4);OH, and one of R1 and R2 is selected from H, OH and OCH3, and the other of R1 and R2 is selected from OH and OCH3; one of R3 and R4 is selected from H, OH and OCH3, and the other of R3 and R4 is selected from OH and OCH3; provided that at least one of the pairs R1, R2 and R3, R4 are both OH; R5 is selected from OH and OCH3; and ~ denotes a single or double bond; and pharmaceutically acceptable salts and prodrugs thereof. The compounds of the invention are useful for the treatment of hormone-dependent conditions and cancers.

Cette invention a trait à des composés correspondant à la formule (I) ou à la formule (II) ainsi qu'à leurs sels, admissibles du point de vue pharmaceutique, et à leurs promédicaments. Dans ces formules, A est choisi dans le groupe constitué par (1), (2), (3), ou (4) et l'un des deux symboles, R¿1?, R¿2?, est choisi dans le groupe constitué par H, OH et OCH¿3?, l'autre symbole, R¿1?, R¿2?, étant choisi entre OH et OCH¿3?, l'un des deux symboles, R¿3?,R¿4?, est choisi dans le groupe constitué par H, OH et OCH¿3?, l'autre symbole, R¿3?, R¿4?, étant choisi entre OH et OCH¿3?, à condition qu'au moins l'une des paires R¿1?, R¿2? et R¿3?, R¿4? représente OH, R¿5? est choisi entre OH et OCH¿3? et la ligne ----- symbolise une liaison simple ou double. Ces composés se révèlent des plus utiles en matière de traitement d'états pathologiques liés aux hormones et de cancers.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Isoflavone metabolites does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoflavone metabolites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoflavone metabolites will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2023768

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.